OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
OncoSec Medical Cash and Short Term Investments (Quarterly)
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2023 | 3.683M |
| October 31, 2022 | 5.730M |
| July 31, 2022 | 12.30M |
| April 30, 2022 | 19.48M |
| January 31, 2022 | 25.23M |
| October 31, 2021 | 35.71M |
| July 31, 2021 | 45.95M |
| April 30, 2021 | 54.39M |
| January 31, 2021 | 60.33M |
| October 31, 2020 | 23.98M |
| July 31, 2020 | 20.35M |
| April 30, 2020 | 30.08M |
| January 31, 2020 | 9.256M |
| October 31, 2019 | 16.95M |
| July 31, 2019 | 25.15M |
| April 30, 2019 | 23.26M |
| January 31, 2019 | 28.73M |
| October 31, 2018 | 28.47M |
| July 31, 2018 | 26.98M |
| April 30, 2018 | 30.28M |
| January 31, 2018 | 17.90M |
| October 31, 2017 | 14.66M |
| July 31, 2017 | 11.44M |
| April 30, 2017 | 16.11M |
| January 31, 2017 | 20.54M |
| Date | Value |
|---|---|
| October 31, 2016 | 24.35M |
| July 31, 2016 | 28.75M |
| April 30, 2016 | 24.02M |
| January 31, 2016 | 28.85M |
| October 31, 2015 | 26.90M |
| July 31, 2015 | 32.04M |
| April 30, 2015 | 25.44M |
| January 31, 2015 | 30.70M |
| October 31, 2014 | 33.99M |
| July 31, 2014 | 37.85M |
| April 30, 2014 | 24.25M |
| January 31, 2014 | 18.45M |
| October 31, 2013 | 15.19M |
| July 31, 2013 | 4.970M |
| April 30, 2013 | 7.329M |
| January 31, 2013 | 8.982M |
| October 31, 2012 | 3.530M |
| July 31, 2012 | 5.142M |
| April 30, 2012 | 6.570M |
| January 31, 2012 | 0.4562M |
| October 31, 2011 | 1.409M |
| July 31, 2011 | 2.458M |
| April 30, 2011 | 0.5429M |
| January 31, 2011 | 0.0037M |
| October 31, 2010 | 0.0002M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |
| Vericel Corp. | 162.46M |